These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 23435422

  • 1. MYC activity is negatively regulated by a C-terminal lysine cluster.
    Wasylishen AR, Kalkat M, Kim SS, Pandyra A, Chan PK, Oliveri S, Sedivy E, Konforte D, Bros C, Raught B, Penn LZ.
    Oncogene; 2014 Feb 20; 33(8):1066-72. PubMed ID: 23435422
    [Abstract] [Full Text] [Related]

  • 2. MYC phosphorylation at novel regulatory regions suppresses transforming activity.
    Wasylishen AR, Chan-Seng-Yue M, Bros C, Dingar D, Tu WB, Kalkat M, Chan PK, Mullen PJ, Huang L, Meyer N, Raught B, Boutros PC, Penn LZ.
    Cancer Res; 2013 Nov 01; 73(21):6504-15. PubMed ID: 24030976
    [Abstract] [Full Text] [Related]

  • 3. Bax is a transcriptional target and mediator of c-myc-induced apoptosis.
    Mitchell KO, Ricci MS, Miyashita T, Dicker DT, Jin Z, Reed JC, El-Deiry WS.
    Cancer Res; 2000 Nov 15; 60(22):6318-25. PubMed ID: 11103792
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
    Bazarov AV, Adachi S, Li SF, Mateyak MK, Wei S, Sedivy JM.
    Cancer Res; 2001 Feb 01; 61(3):1178-86. PubMed ID: 11221849
    [Abstract] [Full Text] [Related]

  • 6. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
    Marampon F, Ciccarelli C, Zani BM.
    Mol Cancer; 2006 Aug 09; 5():31. PubMed ID: 16899113
    [Abstract] [Full Text] [Related]

  • 7. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
    Liebermann DA, Hoffman B.
    Stem Cells; 1994 Jul 09; 12(4):352-69. PubMed ID: 7951003
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lysine-52 stabilizes the MYC oncoprotein through an SCFFbxw7-independent mechanism.
    De Melo J, Kim SS, Lourenco C, Penn LZ.
    Oncogene; 2017 Dec 07; 36(49):6815-6822. PubMed ID: 28806398
    [Abstract] [Full Text] [Related]

  • 11. Identification of a novel c-Myc protein interactor, JPO2, with transforming activity in medulloblastoma cells.
    Huang A, Ho CS, Ponzielli R, Barsyte-Lovejoy D, Bouffet E, Picard D, Hawkins CE, Penn LZ.
    Cancer Res; 2005 Jul 01; 65(13):5607-19. PubMed ID: 15994933
    [Abstract] [Full Text] [Related]

  • 12. New model systems provide insights into Myc-induced transformation.
    Wasylishen AR, Stojanova A, Oliveri S, Rust AC, Schimmer AD, Penn LZ.
    Oncogene; 2011 Aug 25; 30(34):3727-34. PubMed ID: 21441954
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Integrated control of cell proliferation and cell death by the c-myc oncogene.
    Evan G, Harrington E, Fanidi A, Land H, Amati B, Bennett M.
    Philos Trans R Soc Lond B Biol Sci; 1994 Aug 30; 345(1313):269-75. PubMed ID: 7846125
    [Abstract] [Full Text] [Related]

  • 15. Inactivation of MAP kinase signalling in Myc transformed cells and rescue by LiCl inhibition of GSK3.
    Al-Assar O, Crouch DH.
    Mol Cancer; 2005 Apr 05; 4(1):13. PubMed ID: 15811177
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E, Jensen MR, Thorgeirsson SS.
    Cancer Res; 1998 Jan 01; 58(1):123-34. PubMed ID: 9426068
    [Abstract] [Full Text] [Related]

  • 20. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
    Choe C, Chen N, Sawadogo M.
    Exp Cell Res; 2005 Jan 01; 302(1):1-10. PubMed ID: 15541720
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.